FDA NDC Directory · JSON-LD · Markdown

Forteo

NDC 0002-8400 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameTeriparatide
Labeler / ManufacturerEli Lilly and Company
Marketing categoryNew Drug Application (innovator) · App NDA021318
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsTERIPARATIDE (250 ug/mL)
Marketing started20021126
Marketing ended20270202
Package count1

External sources

Source: openFDA. Public-domain (CC0).